Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Medicare Part D payments for neurologist-prescribed drugs.
Multiple sclerosis and progressive resistance training: a systematic review.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Systematic approaches to central nervous system myelin.
High dose naltrexone for dyskinesias induced by levodopa.
Cognitive impairment and cortical degeneration in neuromyelitis optica.
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Progress in multiple sclerosis research in the last year.
Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
Study Suggests Targeting B Cells May Help with MS
High dose thiamine improves fatigue in multiple sclerosis.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Animal Models in Neurology: Drawbacks and Opportunities.
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Complementary and alternative medicine in multiple sclerosis.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Microvesicles: novel biomarkers for neurological disorders.

Pages